Wolverine Trading’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-6,667
| Closed | -$901K | – | 5636 |
|
|
2025
Q2 | $841K | Sell |
6,667
-19,617
| -75% | -$2.44M | ﹤0.01% | 2485 |
|
|
2025
Q1 | $3.64M | Sell |
26,284
-32,929
| -56% | -$4.71M | ﹤0.01% | 1193 |
|
|
2024
Q4 | $8.89M | Buy |
59,213
+51,092
| +629% | +$8.62M | 0.01% | 847 |
|
|
2024
Q3 | $1.58M | Sell |
8,121
-2,314
| -22% | -$484K | ﹤0.01% | 1899 |
|
|
2024
Q2 | $2.42M | Buy |
10,435
+2,582
| +33% | +$561K | ﹤0.01% | 1464 |
|
|
2024
Q1 | $1.69M | Buy |
7,853
+1,206
| +18% | +$282K | ﹤0.01% | 1738 |
|
|
2023
Q4 | $1.72M | Sell |
6,647
-8,017
| -55% | -$1.97M | ﹤0.01% | 1821 |
|
|
2023
Q3 | $3.77M | Buy |
14,664
+8,957
| +157% | +$2.4M | ﹤0.01% | 1160 |
|
|
2023
Q2 | $1.61M | Buy |
5,707
+4,578
| +405% | +$1.36M | ﹤0.01% | 1623 |
|
|
2023
Q1 | $311K | Sell |
1,129
-10,579
| -90% | -$2.93M | ﹤0.01% | 2976 |
|
|
2022
Q4 | $3.24M | Sell |
11,708
-3,152
| -21% | -$890K | ﹤0.01% | 1111 |
|
|
2022
Q3 | $3.93M | Sell |
14,860
-4,365
| -23% | -$927K | 0.01% | 972 |
|
|
2022
Q2 | $3.95M | Sell |
19,225
-1,152
| -6% | -$235K | 0.01% | 917 |
|
|
2022
Q1 | $4.3M | Sell |
20,377
-5,460
| -21% | -$1.19M | 0.01% | 1163 |
|
|
2021
Q4 | $6.2M | Buy |
25,837
+10,835
| +72% | +$2.79M | 0.01% | 1008 |
|
|
2021
Q3 | $4.28M | Sell |
15,002
-5,267
| -26% | -$1.73M | ﹤0.01% | 1423 |
|
|
2021
Q2 | $7.01M | Sell |
20,269
-5,162
| -20% | -$1.56M | 0.01% | 889 |
|
|
2021
Q1 | $7.02M | Sell |
25,431
-15,103
| -37% | -$4.07M | 0.01% | 902 |
|
|
2020
Q4 | $9.87M | Buy |
40,534
+19,529
| +93% | +$5.04M | 0.02% | 679 |
|
|
2020
Q3 | $5.93M | Buy |
21,005
+2,415
| +13% | +$674K | 0.01% | 761 |
|
|
2020
Q2 | $4.84M | Sell |
18,590
-845
| -4% | -$254K | 0.01% | 823 |
|
|
2020
Q1 | $6.14M | Sell |
19,435
-10,781
| -36% | -$3.27M | 0.02% | 656 |
|
|
2019
Q4 | $8.94M | Sell |
30,216
-20,655
| -41% | -$5.73M | 0.02% | 727 |
|
|
2019
Q3 | $11.7M | Buy |
50,871
+22,618
| +80% | +$5.27M | 0.03% | 458 |
|
|
2019
Q2 | $6.61M | Sell |
28,253
-14,262
| -34% | -$3.29M | 0.02% | 733 |
|
|
2019
Q1 | $10.1M | Buy |
42,515
+36,921
| +660% | +$11.6M | 0.03% | 499 |
|
|
2018
Q4 | $1.64M | Buy |
+5,594
| New | +$1.79M | ﹤0.01% | 1574 |
|
|
2018
Q3 | – | Sell |
-12,660
| Closed | -$4.36M | – | 4932 |
|
|
2018
Q2 | $3.47M | Hold |
12,660
| – | – | 0.01% | 1152 |
|
|
2018
Q1 | $3.47M | Sell |
12,660
-13,545
| -52% | -$4.2M | 0.01% | 1152 |
|
|
2017
Q4 | $8.35M | Buy |
26,205
+23,511
| +873% | +$7.54M | 0.03% | 586 |
|
|
2017
Q3 | $844K | Sell |
2,694
-26,898
| -91% | -$7.96M | ﹤0.01% | 2058 |
|
|
2017
Q2 | $8.04M | Buy |
+29,592
| New | +$7.82M | 0.04% | 459 |
|
|
2016
Q3 | – | Sell |
-1,352
| Closed | -$323K | – | 4593 |
|
|
2016
Q2 | $323K | Buy |
+1,352
| New | +$356K | ﹤0.01% | 2710 |
|
Other funds holding BIIB
Wolverine Trading's BIIB Position: Q3 2025 in Review
Wolverine Trading sold out of Biogen (BIIB) in Q3 2025, closing a stake of 6,667 shares — an estimated $901K sold.
Wolverine Trading first reported a position in BIIB in Q2 2016 and held it in 33 quarters. The position peaked at $11.7M in Q3 2019. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.
- Wolverine Trading reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
- Wolverine Trading sold 6,667 Biogen shares in Q3 2025, an estimated $901K.
- Wolverine Trading first reported a position in Biogen in Q2 2016 and held it in 33 quarters.
- Wolverine Trading's Biogen position peaked at $11.7M in Q3 2019.
- 905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.